ArticleMolecular therapy. Oncology2024

Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity.

Dongjiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.